BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mizoshita T, Tsukamoto T, Inada K, Ogasawara N, Hirata A, Kato S, Joh T, Itoh M, Yamamura Y, Tatematsu M. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa. Pathol Int 2004;54:392-400. [PMID: 15144397 DOI: 10.1111/j.1440-1827.2004.01647.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Tatematsu M, Tsukamoto T, Mizoshita T. History of Gastric Carcinoma Research in Japan: Basic Aspects. In: Kaminishi M, Takubo K, Mafune K, editors. The Diversity of Gastric Carcinoma. Tokyo: Springer-Verlag; 2005. pp. 3-28. [DOI: 10.1007/4-431-27713-7_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Mizoshita T, Tsukamoto T, Tanaka H, Takenaka Y, Kato S, Cao X, Joh T, Tatematsu M. Colonic and small-intestinal phenotypes in gastric cancers: Relationships with clinicopathological findings. Pathol Int 2005;55:611-8. [DOI: 10.1111/j.1440-1827.2005.01878.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
3 Ha Kim G, Am Song G, Youn Park D, Han Lee S, Hyun Lee D, Oh Kim T, Jae Jo H, Heo J, Hwan Kang D, Cho M. CDX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype. Scand J Gastroenterol. 2006;41:880-886. [PMID: 16803685 DOI: 10.1080/00365520500497140] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
4 Tsukamoto T, Toyoda T, Mizoshita T, Tatematsu M. Helicobacter pylori infection and gastric carcinogenesis in rodent models. Semin Immunopathol. 2013;35:177-190. [PMID: 23111700 DOI: 10.1007/s00281-012-0357-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
5 Hayakawa M, Nishikura K, Ajioka Y, Aoyagi Y, Terai S. Re-evaluation of Phenotypic Expression in Differentiated-type Early Adenocarcinoma of the Stomach. Pathol Int 2017;67:131-40. [PMID: 28088838 DOI: 10.1111/pin.12506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
6 Okamoto N, Kawachi H, Yoshida T, Kitagaki K, Sekine M, Kojima K, Kawano T, Eishi Y. “Crawling-type” adenocarcinoma of the stomach: a distinct entity preceding poorly differentiated adenocarcinoma. Gastric Cancer 2013;16:220-32. [DOI: 10.1007/s10120-012-0173-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
7 Tsukamoto T, Yokoi T, Maruta S, Kitamura M, Yamamoto T, Ban H, Tatematsu M. Gastric adenocarcinoma with chief cell differentiation. Pathol Int. 2007;57:517-522. [PMID: 17610477 DOI: 10.1111/j.1440-1827.2007.02134.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
8 McCluggage WG, Shah R, Connolly LE, McBride HA. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2. Int J Gynecol Pathol. 2008;27:92-100. [PMID: 18156982 DOI: 10.1097/pgp.0b013e31815698e7] [Cited by in Crossref: 70] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]
9 Tanaka H, Tsukamoto T, Mizoshita T, Inada K, Ogasawara N, Cao X, Kato S, Joh T, Tatematsu M. Expression of small intestinal and colonic phenotypes in complete intestinal metaplasia of the human stomach. Virchows Arch 2005;447:806-15. [PMID: 16088401 DOI: 10.1007/s00428-005-0040-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
10 Wang XT, Wei WY, Kong FB, Lian C, Luo W, Xiao Q, Xie YB. Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures. J Exp Clin Cancer Res. 2012;31:98. [PMID: 23181722 DOI: 10.1186/1756-9966-31-98] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
11 Watanabe G, Ajioka Y, Takeuchi M, Annenkov A, Kato T, Watanabe K, Tani Y, Ikegami K, Yokota Y, Fukuda M. Intestinal metaplasia in Barrett's oesophagus may be an epiphenomenon rather than a preneoplastic condition, and CDX2-positive cardiac-type epithelium is associated with minute Barrett's tumour. Histopathology 2015;66:201-14. [PMID: 25040564 DOI: 10.1111/his.12486] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
12 Song JH, Kim CJ, Cho YG, Chae JS, Cao Z, Nam SW, Lee JY, Park WS. Genetic alterations of the Cdx2 gene in gastric cancer. APMIS. 2008;116:74-80. [PMID: 18254783 DOI: 10.1111/j.1600-0463.2008.00881.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
13 Nozawa Y, Nishikura K, Ajioka Y, Aoyagi Y. Relationship between alpha-methylacyl-coenzyme A racemase expression and mucin phenotype in gastric cancer. Hum Pathol 2012;43:878-87. [PMID: 22078291 DOI: 10.1016/j.humpath.2011.07.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
14 Mori Y, Kataoka H, Miura Y, Kawaguchi M, Kubota E, Ogasawara N, Oshima T, Tanida S, Sasaki M, Ohara H, Mizoshita T, Tatematsu M, Asai K, Joh T. Subcellular localization of ATBF1 regulates MUC5AC transcription in gastric cancer. Int J Cancer 2007;121:241-7. [PMID: 17330845 DOI: 10.1002/ijc.22654] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
15 Otsuka T, Tsukamoto T, Mizoshita T, Inada K, Takenaka Y, Kato S, Yamamura Y, Miki K, Tatematsu M. Coexistence of gastric- and intestinal-type endocrine cells in gastric and intestinal mixed intestinal metaplasia of the human stomach. Pathol Int 2005;55:170-9. [PMID: 15826243 DOI: 10.1111/j.1440-1827.2005.01809.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
16 Dang LH, Chen F, Knock SA, Huang EH, Feng J, Appelman HD, Dang DT. CDX2 does not suppress tumorigenicity in the human gastric cancer cell line MKN45. Oncogene. 2006;25:2048-2059. [PMID: 16331267 DOI: 10.1038/sj.onc.1209243] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
17 Ge J, Chen Z, Wu S, Yuan W, Hu B, Chen Z. A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma. Clin Oncol (R Coll Radiol). 2008;20:275-283. [PMID: 18353622 DOI: 10.1016/j.clon.2008.01.013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
18 Goldstein NS, Bosler DS. Immunohistochemistry of the Gastrointestinal Tract, Pancreas, Bile Ducts, Gallbladder and Liver. Diagnostic Immunohistochemistry. Elsevier; 2006. pp. 442-508. [DOI: 10.1016/b978-0-443-06652-8.50019-3] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
19 Heatley MK. Immunohistochemical biomarkers of value in distinguishing primary ovarian carcinoma from gastric carcinoma: a systematic review with statistical meta-analysis. Histopathology 2008;52:267-76. [DOI: 10.1111/j.1365-2559.2007.02824.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
20 Mizoshita T, Tsukamoto T, Cao X, Otsuka T, Ito S, Takahashi E, Nakamura S, Nakamura T, Yamamura Y, Tatematsu M. Microsatellite instability is linked to loss of hMLH1 expression in advanced gastric cancers: lack of a relationship with the histological type and phenotype. Gastric Cancer. 2005;8:164-172. [PMID: 16086119 DOI: 10.1007/s10120-005-0331-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
21 Ahn SY, Lee SY, Hong SN, Kim JH, Sung IK, Park HS, Shim CS, Jin CJ, Han HS. Endoscopic diagnosis of open-type atrophic gastritis is related to the histological diagnosis of intestinal metaplasia and Cdx2 expression. Dig Dis Sci. 2011;56:1119-1126. [PMID: 21221798 DOI: 10.1007/s10620-010-1531-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
22 Ikarashi S, Nishikura K, Ajioka Y, Aoyagi Y. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2. Gastric Cancer. 2013;16:208-219. [PMID: 22829163 DOI: 10.1007/s10120-012-0172-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
23 Ito R, Oue N, Yoshida K, Kunimitsu K, Nakayama H, Nakachi K, Yasui W. Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer. Virchows Arch. 2005;447:717-722. [PMID: 16044349 DOI: 10.1007/s00428-005-0015-2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.2] [Reference Citation Analysis]
24 Han WH, Eom BW, Yoon HM, Kim YW, Kook MC, Ryu KW. The Different Clinicopathological Features of Remnant Gastric Cancer Depending on Initial Disease of Partial Gastrectomy. Cancers (Basel) 2020;12:E2847. [PMID: 33023082 DOI: 10.3390/cancers12102847] [Reference Citation Analysis]
25 Takeo H, Matsukuma S. Gastric tube cancer: immunohistochemical study of 10 lesions in six patients. J Gastroenterol Hepatol 2007;22:23-9. [PMID: 17201876 DOI: 10.1111/j.1440-1746.2006.04466.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
26 Shiotani A, Kamada T, Yamanaka Y, Manabe N, Kusunoki H, Hata J, Haruma K. Sonic hedgehog and CDX2 expression in the stomach. J Gastroenterol Hepatol. 2008;23 Suppl 2:S161-S166. [PMID: 19120891 DOI: 10.1111/j.1440-1746.2008.05406.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
27 Tsukamoto T, Mizoshita T, Tatematsu M. Animal models of stomach carcinogenesis. Toxicol Pathol. 2007;35:636-648. [PMID: 17654405 DOI: 10.1080/01926230701420632] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
28 Tatematsu M, Tsukamoto T, Mizoshita T. Role of Helicobacter pylori in gastric carcinogenesis: the origin of gastric cancers and heterotopic proliferative glands in Mongolian gerbils. Helicobacter. 2005;10:97-106. [PMID: 15810939 DOI: 10.1111/j.1523-5378.2005.00305.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
29 Tsukamoto T, Mizoshita T, Mihara M, Tanaka H, Takenaka Y, Yamamura Y, Nakamura S, Ushijima T, Tatematsu M. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Histopathology. 2005;46:649-658. [PMID: 15910596 DOI: 10.1111/j.1365-2559.2005.02170.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 74] [Article Influence: 4.5] [Reference Citation Analysis]
30 Kato S, Matsukura N, Tsukada K, Matsuda N, Mizoshita T, Tsukamoto T, Tatematsu M, Sugisaki Y, Naito Z, Tajiri T. Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics. Cancer Sci. 2007;98:790-794. [PMID: 17470129 DOI: 10.1111/j.1349-7006.2007.00478.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 4.5] [Reference Citation Analysis]
31 Yagi K, Nagayama I, Hoshi T, Abe S, Morita SI, Suda T, Hasegawa G, Sato YI, Terai S. Green epithelium revealed by narrow-band imaging (NBI): a feature for practical assessment of extent of gastric cancer after H. pylori eradication. Endosc Int Open 2018;6:E1289-95. [PMID: 30410947 DOI: 10.1055/a-0746-3449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]